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  “’e investigated the effect of antimicrobial agents against bacteria within infected stones． Cefmetazele
（CMZ） was found to have equally strong activities against gramLpositive and gram－negative bacteria isolated
丘om the stoncs． hl addi亡ioll， CMZ was excre亡ed in the urine from the affected kidney in｝high concentrations
and was penetrated into the stone to some extent in vitro． However， preoperative administration of CMZ
did not so signifi cantly eradicate bacteria within the stones．
  Stones may function as a sanctuary for organisms and rnay attenuate the effects of antibiotics against
them． Therefore， te treat urinary tract infection associated with urinary calculi， complete extirpation is
nessesary．
  In recent years， ultrasonic and other types of stone crushing methods are in wide use． CMZ or other
cffective antibiotics may become useful for the perioperative management of infected urinary stones．
                              （Acta Uro1． Jpn． 35： 755一一761， 1989）



















            泌尿紀要．．35巻 5号 1989年
1solated bacteria from． urine and stone ininfection st pe cases
Case     Urine
Pyuria’@’@’bIItuie
    Stone culture
Su．r．．face ． lnside
Control
  1 十3 Cbrynebacterium
  2 ’十3． S，saprophyticus
  3 ＋3 P．mirabilis
  4 十3 P．mirabili＄
  5 十3 P．mitabilis
  6 ＋3 E．coli
  7 十3 K，pneurnoniae
  8 ＋3． S．marcescens
              P．rettgeTi
  9 十1 P．mirabilis
  10 ＋1 P．mirabijis
  11 十3 S，aureus
  12 ＋1 P．mirabilis
  13 十2 S．saprophyticus
  14 十2 S，liquefaciens
 l5 ’ 十3 Ps，aeruginosa
 16 十3 E，coli
              P，mirabilis
  17 ＋1 P，mirabiiis
CMZ treated
 18 十3 ． Pmirabilis
  19 十3 P，mirabilis
              E．coli
 2e ＋3 S．epidermidis
 21 十1 P．mirabilis
 22 十3・ P．rriirabilis
 23 十3 ・ E．coli
 24 ＋3 P，mirabilis
 2s ＋1 ． S．epidermidis
              E．faecalis
 26 ’＋ 1 S，epidermidis
              Ps．aeruginosa
 27 十1 E，coli
 28 ’ 十1 E．coli
 2g 十’1 M．morganii
              S．ep’idermidis
 30 十3 H．influenzae
O・ther antibiotics treated
 31 十3 P．mirabilis
 32 ．＋1 ・． S，saprophyti．cus
 33 ＋3 Ps．aergginosa，
34 ・＋1． P．vulgaris
 35’ 十3 Ps．aeruginosa
              A．anitratus
 36 十3 E，coli






































































Table 2． lsolated bacteria from urine and stone in metabolic stones
Case Utine
    Pyuria Culture




















































































S． marcescens S． marcescens
S． epidermidis S． epidermidis
＋3 Ps． aeruginosa E． coli










zole－trimetoprim （ST）， nalidixic acid （NA），一
fosfomycin （FSM）， amplcillin （ABPC）， mino－

































dis 1例， P． mirabilis I例， S． epidermidisと
E・faecalisの1例， M． morganiiとS． epidermi－
disの1例， H． influenza 1例であった． H． influ－
enzaはあまり尿中より分離されず，問題があるかも
Table 3．Effect of antibiotics on viability of
bacteria on the surface of the stones
and inside of the stones
         Inf． stone
 Positive








16／17 16／17 6／12． 6／12
8／i3＊ 8／13＊ 3／7 4／7
7／7 7／7 1／3 1／3
＊O．05〈P〈O．10
Table 4．2Minimum inhibitory concentration
           （108CFU／mの（μ9／mの
CMZ CEZ CZX LMOX PIPC
P． mirabilis
  （n三29）
MICso 1．56 6．25 ＄O．10 O．20 O．78
MICso 3．13 6．25 SO．10 O．39 O．78
P． indole（十）
  （n＝12）
MICso 1．56 100 El；Q．10 O．10 O．78
MICso 3．13 100 SO．10 ．0．39 3．13
E． coli
  （n＝21＞
MICse O．78 3．13 ＄O．10 o．lo O．78
MICBo 1．56 6．25 O．10 O．39 1．56
Staphylococcus sp． MICso 1．56 O．78 1．56





MICso ＞100 ＞100 50
































    affected normat     kidney kldney






．Concentration of serum and ．urine after intravenous
administration of i g・or 2 g CMZ
759
（Case l） CMZ 1 g
CMZ concentration pt g／me 1（me） Recovery mg（O／e）




860（40） 400｛15） 34．4（3．4） 6．0（O．6）
970（500） 1780（130） 485（48．5） 231（23．1）
44．0 57．0





315〈55） 230（80＞ 17．3（O．9） 18；4’一（O．9）
























 t ptsts．． Surface Center         stone
Fig． 2． Distribution of CMZ into the stone ・



























Results of treatment for urinarY tract infections
associated with urinary calculi
  Pyuria． Cleared
Baeteriuria
DecreasedUnchanged Efficacy on
      bacteriuria
Eliminated 211 3 25
Decreased 2 2
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